IOL Chemicals and Pharmaceuticals Limited – SWOT Analysis

Strengths Integrated Chemical & Pharma Business – Strong presence in APIs, specialty chemicals, and industrial chemicals provides business diversification. Leading Ibuprofen API Player – One of the major global manufacturers of ibuprofen API, creating scale and export strength. Strong Export Revenue – Significant international sales help diversify market dependence and improve growth potential. Weaknesses High Dependence on Ibuprofen – Significant revenue concentration in one major product increases business risk. Commodity Price Sensitivity – Raw material and solvent price volatility directly impacts profitability. Cyclical Chemical Segment Exposure – Specialty and industrial chemical demand can fluctuate with economic conditions. Opportunities Global API Demand Growth – Increasing outsourcing and pharma demand support export expansion. China+1 Opportunity – Global buyers diversifying from China can benefit Indian API manufacturers. Government Support for Pharma Manufacturing – PLI schemes and Make in India initiatives support long-term expansion. Threats USFDA / Regulatory Issues – Any compliance issue may impact exports and reputation. Pricing Pressure from China – Chinese API competition can reduce margins and market share. Raw Material Inflation – Input cost increases may hurt profitability. Currency Volatility – Forex fluctuations affect export realization and import costs. Environmental Compliance Costs – Chemical manufacturing faces stricter pollution and sustainability regulations. Disclaimer AASHISH SEBI RA INH000013174 This analysis is only for educational and informational purposes and should not be considered as buy/sell recommendation. Investors should consult their financial advisor before making any investment decision. Stock market investments are subject to market risks. Past performance does not guarantee future results.